Skip to content

Prevalence of patent foramen ovale (PFO) in patients with angina and documented coronary artery vasospasm

Prevalence of patent foramen ovale (PFO) in patients with angina and documented coronary artery vasospasm - PROVA-study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON51029
Enrollment
100
Registered
2021-08-19
Start date
2021-10-12
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patent Foramen Ovale

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Adult patients with documented coronary artery vasospasm with an intracoronary acetylcholine provocation testing - Able to measure oxygen saturation with a pulsoximeter - Able to undergo TTE with agitated saline testing - Able to perform Valsalva manoeuvre for reliable RLS assessment - Able to undergo VO2max exercise testing

Exclusion criteria

Exclusion criteria: - Life expectancy

Design outcomes

Primary

MeasureTime frame
- Prevalence of PFO and RLS in patients with documented coronary artery vasospasm (TTE with agitated-saline) - Quality of Life at baseline --> Seattle Angina Questionnaires (SAQ) score and Migraine Disability Assessment Questionnaire (MIDAS) score

Secondary

MeasureTime frame
- Exercise testing in patients with coronary artery vasospasm and RLS - QoL during follow up - Number of episodes of angina symptoms will be assessed - Number of episodes of migraine headaches will be assessed - Association between exercise capacity, QoL and exercise-related oxygen (de)saturation in patients with coronary artery vasospasm and a RLS - Measurement of VO2 max during exercise testing - Measurement of oxygen saturation

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)